Neurone
Biotechnology Research • 
Chilvester Hill, Chilvester lodge, United Kingdom • 1-10 Employees
Company overview
| Headquarters | Chilvester Hill, Chilvester lodge, Calne, England SN11 0LP, GB |
| NAICS | 541714 |
| Keywords | Clinical Trials, FDA, CBD, Analytical Chemistry, Cannabis, Good Manufacturing Practice, THC, Controlled Drugs, Botanical Extracts, Cannabinoid Science, Botanical Medicines |
| Founded | 2021 |
| Employees | 1-10 |
Key Contact at Neurone
Alan Sutton
Director of Botanical Chemistry
About Neurone
UK company developing complex botanical pharmaceuticals from extracts of Cannabis Sativa As former members of the GW Pharmaceuticals executive team, where we learned to develop FDA approved medicines from the cannabis plant, we have established Neurone to enable us to pursue the development and approval of the next generation of cannabis based pharmaceuticals. We use complex botanical extracts, obtained from botanical raw material grown in our licensed growing facility, to create novel extract based pharmaceutical products. We will develop IP protected, complex botanical medicines, executing the clinical trials required to secure FDA and other international regulatory approvals in order to enable prescribing and reimbursement needed to achieve broad patient access.
Neurone revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Neurone has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Neurone has never raised funding before.
United States
Spain
Netherlands
Canada
Czechia
France
Frequently asked questions
4.8
40,000 users
